PPARγ拮抗剂,G3335(25毫克)产品是Cell-permeable. A dipeptide that acts as a selective and reversible PPARγ antagonist (KD ~ 8 uM). Shown to inhibit the agonist activity of Rosiglitazone (100 nM) in a dose-dependent manner (IC₅₀ = 31.9 uM) in transfected COS-7 cells.